Best ADC Platform Technology

Winner – Fleximer (Mersana Therapeutics)

Runner Up – Bicycles (Bicycle Therapeutics)

 

Most Promising Clinical Candidate

Winner – Rovalpituzumab tesirine (Abbvie-Stemcentrx)

Runner Up – MEDI4276 (MedImmune)

 

Best Contract Manufacturing (CMO) Provider

Winner - BSP Pharmaceuticals

Runner Up - Piramal

 

Best Contract Research (CRO) Provider

Winner - Abzena

 

Best New Drug Developer sponsored by Pfizer

Winner - ADC Therapeutics

Runner Up – Mersana Therapeutics

 

Best Publication 2015

Winner - Saunders et al., A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. Sci Transl Med., 2015.

Runner Up - van Geel et al., Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody−Drug Conjugates; Bioconj. Chem., 2015.

 

Best Poster sponsored by Abbvie

Winner - Computational Exploration of Mechanistic Determinants of ADC Pharmacokinetics Using QSP Modeling Strategies; AK Wilkens et al.

Runner Up - Discovery and Characterization of ADCs with a Novel Mode of Action; G Piizzi et al.

 

Individual Input to the Field 2015/2016

Winner - David Thurston

Runner Up - Scott Dylla

 

Long Standing Contribution

Winner - John Lambert